BIO — Bio Rad Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapSuper Stock

Annual balance sheet for Bio Rad Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	991	870	1,791	1,607	1,665
Net Total Accounts Receivable
Net Total Receivables	419	424	495	489	453
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,140	1,990	3,158	3,048	3,030
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	694	716	680	724	689
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	12,973	17,799	13,502	12,299	9,364
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	632	681	569	523	468
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	3,093	4,114	3,886	3,558	2,795
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	9,880	13,685	9,615	8,741	6,569
Total Liabilities & Shareholders' Equity	12,973	17,799	13,502	12,299	9,364
Total Common Shares Outstanding